Literature DB >> 6894916

Surface activity following natural surfactant treatment in premature lambs.

M Ikegami, A Jobe, T Glatz.   

Abstract

Premature lambs with respiratory failure [CO2 partial pressure (PCO2) greater than 70 Torr] were treated with 50 mg/kg 3H-labeled natural surfactant by tracheal instillation. Minimum surface tensions of sequential samples suctioned from the airways fell from 25 +/- 3 dyn/cm before treatment to 8 +/- 5 dyn/cm after treatment and again rose to 32 +/- 2 dyn/cm at death. Minimum surface tensions of alveolar wash samples taken at death were 27 +/- 4 dyn/cm, whereas surfactant fractions reisolated from the alveolar washes lowered surface tension to under 10 dyn/cm. The alveolar washes, surfactant reisolated from the alveolar washes, and natural surfactant had similar phospholipid compositions; however, the alveolar washes contained about 40 times more protein per micromole phosphatidylcholine. The natural surfactant used for treatment apparently was inactivated by an inhibitor of surfactant function. After intravenous injections of [14C]palmitic acid, labeled saturated phosphatidylcholine appeared on the airways, indicating endogenous synthesis and secretion. However, the specific activity of the 3H-labeled saturated phosphatidylcholine in the natural surfactant used for treatment decreased by only 30 +/- 4% in the alveolar wash; thus the treatment dose was not diluted to a large extent by endogenous pools.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894916     DOI: 10.1152/jappl.1981.51.2.306

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  12 in total

1.  Response to bovine surfactant (surfactant TA) in two different HMD models (lambs and baboons).

Authors:  H Maeta; D Vidyasagar; T Raju; R Bhat; H Matsuda
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

Review 2.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

3.  Turnover of exogenous artificial surfactant.

Authors:  M R Ashton; A D Postle; M A Hall; N C Austin; D E Smith; I C Normand
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

4.  Replacement of surfactant in hyaline membrane disease.

Authors:  D V Walters
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-06

5.  Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant.

Authors:  A Jobe; M Ikegami; H Jacobs; S Jones
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

6.  Advances in respiratory distress syndrome.

Authors:  N R Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-27

7.  In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function.

Authors:  B Lachmann; E P Eijking; K L So; D Gommers
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

8.  Artificial surfactant in preterm rabbits with and without respiratory distress syndrome: difference of in vitro and in vivo activities.

Authors:  M Obladen; W Kampmann; I Zimmermann; B Lachmann
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

9.  Altered lipid synthesis in type II pneumonocytes exposed to lung surfactant.

Authors:  N R Thakur; M Tesan; N E Tyler; J E Bleasdale
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

10.  Effects of bovine surfactant in premature lambs after intra-tracheal application.

Authors:  L Gortner; F Pohlandt; B Disse; E Weller
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.